Endonovo Therapeutics Inc. (ENDV) 5.3100 $ENDV
Endeavour Schedules 2014 Second Quarter Conference Call and Webcast
PR Newswire - Mon Jul 28, 4:37PM CDT
Endeavour International Corporation (NYSE: END) (LSE: ENDV) will host a conference call and webcast to discuss its 2014 second quarter financial and operating results on Tuesday, August 5, 2014 at 9 a.m. Central Time, 3 p.m. British Summer Time.
Endonovo Therapeutics to Develop Next Generation, Off-The-Shelf, Cell Free Regenerative Products
Marketwire - Wed Jun 11, 8:03AM CDT
Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"
, a biotechnology company developing innovative regenerative therapies, announced today that it has created technologies to pursue the development and manufacturing of next generation regenerative products that no longer require the administration of stem cells. Endonovo's "Cell Free" products will harness the biological molecules secreted by cells to create truly "off-the-shelf" therapeutics that can be delivered to patients in a much timelier manner than is possible with autologous and allogeneic stem cell therapies.
Endeavour Comments on Stock Price and Updates Q2 2014 Guidance
PR Newswire - Tue Jun 10, 8:17AM CDT
Endeavour International Corporation (NYSE: END) (LSE: ENDV) today announced that it has received numerous calls from analysts and investors making inquiries regarding recent market activity in the Company's stock. Management of the Company is unaware of any reason why recent trading of the stock has resulted in a significant decrease in its price over the last few days.
Stockholders Elect ALL Endeavour Director Nominees at Annual Meeting
PR Newswire - Thu May 22, 3:15PM CDT
Endeavour International Corporation (NYSE: END) (LSE: ENDV) today announced that, based on the preliminary vote count of its proxy solicitor, Morrow & Co., Endeavour's stockholders have elected all of the Board of Director's director nominees - John B. Connally III, James H. Browning and William D. Lancaster - at the Company's 2014 Annual Meeting of Stockholders.
Endeavour Announces Both Wells on Production at Rochelle Field
PR Newswire - Wed May 21, 8:00AM CDT
Endeavour International Corporation (NYSE: END) (LSE: ENDV) ("Endeavour" or the "Company" today announced that the West Rochelle W1 well has been returned to production. Both West and East Rochelle wells are now flowing together and Rochelle production will be optimized between the two wells in the coming days. The Company may update production guidance for the second quarter, once stabilized production rates have been achieved.
Endeavour to Present at the Howard Weil Energy Conference
PR Newswire - Tue Mar 25, 3:15PM CDT
Endeavour International Corporation (NYSE: END) (LSE: ENDV) today announced that it will present at the Howard Weil's 42nd Annual Energy Conference. William L. Transier, chairman, chief executive officer and president, is scheduled to speak on the company's business strategies and operational plans on Thursday, March 27, 2014 at 11:00 am Central time.
Endeavour Announces New Board Member
PR Newswire - Wed Mar 19, 3:29PM CDT
Endeavour International Corporation (NYSE: END) (LSE: ENDV) today announced that James H. Browning has been appointed to a serve as a Director on the company's Board of Directors. He will serve as an independent director and be appointed to both the Technology & Reserves Committee and Audit Committee, where he qualifies as an "audit committee financial expert."
Endeavour Announces 2013 Fourth Quarter and Year-End Financial and Operational Results
PR Newswire - Wed Mar 05, 1:00AM CST
Endeavour International Corporation (NYSE: END) (LSE: ENDV) today reported fourth quarter 2013 net loss, as adjusted of $24.7 million compared to a net loss, as adjusted of $7.7 million for the same period in 2012. On a GAAP basis, net loss for the fourth quarter was $27.7 million as compared to net loss of $6.5 million for the same quarter in 2012.
Endeavour Schedules 2014 Second Quarter Conference Call and Webcast
PR Newswire - Mon Jul 28, 4:37PM CDT
Endeavour International Corporation (NYSE: END) (LSE: ENDV) will host a conference call and webcast to discuss its 2014 second quarter financial and operating results on Tuesday, August 5, 2014 at 9 a.m. Central Time, 3 p.m. British Summer Time.
Endonovo Therapeutics to Develop Next Generation, Off-The-Shelf, Cell Free Regenerative Products
Marketwire - Wed Jun 11, 8:03AM CDT
Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"
, a biotechnology company developing innovative regenerative therapies, announced today that it has created technologies to pursue the development and manufacturing of next generation regenerative products that no longer require the administration of stem cells. Endonovo's "Cell Free" products will harness the biological molecules secreted by cells to create truly "off-the-shelf" therapeutics that can be delivered to patients in a much timelier manner than is possible with autologous and allogeneic stem cell therapies. Endeavour Comments on Stock Price and Updates Q2 2014 Guidance
PR Newswire - Tue Jun 10, 8:17AM CDT
Endeavour International Corporation (NYSE: END) (LSE: ENDV) today announced that it has received numerous calls from analysts and investors making inquiries regarding recent market activity in the Company's stock. Management of the Company is unaware of any reason why recent trading of the stock has resulted in a significant decrease in its price over the last few days.
Stockholders Elect ALL Endeavour Director Nominees at Annual Meeting
PR Newswire - Thu May 22, 3:15PM CDT
Endeavour International Corporation (NYSE: END) (LSE: ENDV) today announced that, based on the preliminary vote count of its proxy solicitor, Morrow & Co., Endeavour's stockholders have elected all of the Board of Director's director nominees - John B. Connally III, James H. Browning and William D. Lancaster - at the Company's 2014 Annual Meeting of Stockholders.
Endeavour Announces Both Wells on Production at Rochelle Field
PR Newswire - Wed May 21, 8:00AM CDT
Endeavour International Corporation (NYSE: END) (LSE: ENDV) ("Endeavour" or the "Company"
today announced that the West Rochelle W1 well has been returned to production. Both West and East Rochelle wells are now flowing together and Rochelle production will be optimized between the two wells in the coming days. The Company may update production guidance for the second quarter, once stabilized production rates have been achieved. Endeavour to Present at the Howard Weil Energy Conference
PR Newswire - Tue Mar 25, 3:15PM CDT
Endeavour International Corporation (NYSE: END) (LSE: ENDV) today announced that it will present at the Howard Weil's 42nd Annual Energy Conference. William L. Transier, chairman, chief executive officer and president, is scheduled to speak on the company's business strategies and operational plans on Thursday, March 27, 2014 at 11:00 am Central time.
Endeavour Announces New Board Member
PR Newswire - Wed Mar 19, 3:29PM CDT
Endeavour International Corporation (NYSE: END) (LSE: ENDV) today announced that James H. Browning has been appointed to a serve as a Director on the company's Board of Directors. He will serve as an independent director and be appointed to both the Technology & Reserves Committee and Audit Committee, where he qualifies as an "audit committee financial expert."
Endeavour Announces 2013 Fourth Quarter and Year-End Financial and Operational Results
PR Newswire - Wed Mar 05, 1:00AM CST
Endeavour International Corporation (NYSE: END) (LSE: ENDV) today reported fourth quarter 2013 net loss, as adjusted of $24.7 million compared to a net loss, as adjusted of $7.7 million for the same period in 2012. On a GAAP basis, net loss for the fourth quarter was $27.7 million as compared to net loss of $6.5 million for the same quarter in 2012.
